Over the past two decades complement research has seen a breathtaking development, and progress related to complement-mediated diseases has resulted in life-transforming advancements in patient management. Nevertheless, research and clinical translation thereof are still only at their beginnings, and there is a tremendous opportunity for education and learning in the complement field. In response to this development, we launched the new international Toronto Complement Conference (TCC) in 2020, aiming to gather scientists, clinicians, and allied health professionals from North America and all over the world to discuss the latest topics in the complement field-in science and in the clinical arena.

For TCC 2024 we once again composed an exciting program with stellar faculty being internationally recognized for topics of great interest including TMA, C3G, and novel treatments. We are also offering an exciting event in the form of a Young Investigators Forum as well as the Pharma & Biotech Innovations Session where healthcare companies will have an opportunity to present their research and development in the complement space.

Welcome to TCC 2024-we hope you will enjoy the conference!